NCT06056258View on ClinicalTrials.gov

A Study to Evaluate the Efficacy of VL-NL-02 on Sleep Quality.

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Mood and Sleep Quality
Interventions
DIETARY_SUPPLEMENT

VL-NL-02

Two capsules to be taken 45±10 mins before sleep (after dinner) for 21 days

DIETARY_SUPPLEMENT

Placebo

Two capsules to be taken 45±10 mins before sleep (after dinner) for 21 days

Trial Locations (5)

305001

Arora Allergy Asthma and Chest Care Hospital, Ajmer

410206

Sparsh Hospital, Navi Mumbai

411011

Dhanwantari Hospital, Pune

421203

BAJ RR Hospital, Dombivali

422003

Surya Multispeciality Hospital, Nashik

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT06056258 - A Study to Evaluate the Efficacy of VL-NL-02 on Sleep Quality. | Biotech Hunter | Biotech Hunter